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ABSTRACT 
Evaluation of the Effect of Progesterone CIDR Devices on Circulating 
Levels of Progesterone in Cyclic Ewes.  (December 2004) 
Michael Carey Satterfield, B.S., Texas A&M University 
Co-Chairs of Advisory Committee:  Dr. W. Shawn Ramsey 
          Dr. Thomas E. Spencer 
 
 
 A homogeneous group of thirty-one crossbred ewes was used to determine the 
effect of administering a progesterone Controlled Intravaginal Drug Releasing 
Device (CIDR) on circulating levels of progesterone in the subsequent cycle 
following CIDR removal.  Circulating progesterone levels were determined for each 
ewe through daily blood collection via jugular venipuncture.  Each ewe underwent a 
pretreatment 25 day sampling period (Period 1), a 12 day treatment period 
characterized by the presence of the CIDR (Period 2), and another 25 day sampling 
period following CIDR removal (Period 3).  During the initial period of the study, 
progesterone levels in peripheral circulation changed (P < 0.0001, effect of day) in 
accordance with stage of the estrous cycle and were elevated during the luteal phase.  
In the second period of the study, progesterone levels were elevated (P < 0.0001) in 
ewes due to exogenous progesterone from the CIDR device (Period 1 versus Period 
2:  1.3 ± 0.1 ng/ml versus 2.4 ± 0.1 ng/ml, respectively).  After withdrawal of the 
CIDR in the third period of the study, circulating progesterone levels were not (P > 
0.10) different from those observed in the initial period of the study (Period 1 versus 
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Period 3:  1.3 ± 0.1 ng/ml versus 1.4 ± 0.1 ng/ml, respectively).  Data collected in 
this study revealed that treatment with exogenous progesterone via CIDR for a 12-
day treatment period does not influence circulating levels of progesterone in 
subsequent estrous cycles. 
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     INTRODUCTION 
 The lack of availability of effective and efficient methods for estrus 
synchronization in sheep and goats is a critical detriment to the industry.  The ability 
to rapidly improve genetics, and thus increase profits, is centered around the ability 
to use artificial insemination and embryo transfer.  Both of these advanced 
reproductive techniques require the ability to effectively synchronize estrus.  Unlike 
other domesticated species the ability to traverse the cervix of a ewe is extremely 
difficult, therefore the use of transcervical artificial insemination (AI) is limited in 
the sheep industry.  The predominant method for AI in the United States is through 
laparoscopy.  The expense of equipment and the relatively high skill level required to 
inseminate ewes in this manner adds greater constraints to estrus synchronization 
protocols.  Acceptable protocols must allow for the ability to breed females off of a 
fixed time regimen not daily heat detection as can be done in other species due to the 
ease of insemination.  This constraint severely limits the ability to use prostaglandin 
regimens to synchronize estrus.  Currently the only other method of synchronization 
that yields an acceptable window for timed AI is through the use of long-term 
progesterone treatment.  Daily injections of progesterone are however very labor 
intensive and relatively unfeasible.  The use of subcutaneous ear implants containing 
a progesterone analog was effective, however, they have recently become 
unavailable in the United States.  Progesterone soaked sponges are currently  
______________ 
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available however there are hygienic concerns about this method related to infections 
of the reproductive tract.  The development of a new product, a Controlled 
Intravaginal Drug Releasing Device (CIDR) has recently come to the forefront in 
various countries throughout the world for the synchronization of sheep, goats, and 
cattle.  The objective of this study was to determine if a twelve-day progesterone 
CIDR device treatment significantly increased daily progesterone levels in the 
estrous cycle succeeding the treatment versus the cycle immediately prior to the 
CIDR treatment.          
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LITERATURE REVIEW 
 The administration of exogenous progesterone as a means to manipulate the 
estrous cycle has been widely evaluated throughout the research community.  The 
first attempts to use progesterone as a synchronization device were in cattle in the 
1960s and 1970s (1, 2).  Animals were subjected to daily injections of progesterone 
for a maximum of 20 days.  The results of this treatment yielded acceptable levels of 
synchrony, although fertility at the synchronized estrus was low.  Future research 
focused on other modes of progestin administration due to the impracticality of a 
daily injection protocol.  Oral, transdermal, and eventually intravaginal methods of 
administration were developed and used in estrous synchronization protocols (1).  
The transitions in the mode of administration stemmed from a need to decrease time 
and energy associated with both daily injections and daily oral administration, as 
well as a need for consistent dosage of the hormone which can be difficult when 
feeding oral progesterone.  Unfortunately, the available options are limited for the 
synchronization of estrous using exogenous progesterone in the United States. 
Currently, estrous synchronization in most ruminant species involves one of two 
basic strategies.  These strategies involve either luteolysis of the corpus luteum (CL) 
through administration of prostaglandin F2 alpha (PGF2α) or one of its analogs or 
prolonged treatment with native or synthetic progestins (1, 3, 4).  Prostaglandin F2α 
and its analogues induce estrus through rapid luteal regression of a functional CL and 
the resultant ovulation of a dominant follicle.  However, the use of luteolytic agents 
has restrictions that limit its effectiveness as indicated by the necessity for the 
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presence of a functional CL.  Long-term progestin treatment synchronizes estrus by 
suppressing folliculogenesis through inhibition of hypothalamic function.  Cessation 
of progestin treatment allows folliculogenesis to resume and is followed by ovulation 
(3).  The use of either hormone yields acceptable synchrony in cyclic cattle, although 
PGF2α administration is ineffective during the postpartum interval.  In sheep, 
seasonal considerations, associated with the role of the photoperiod in controlling 
estrous, are critical in determining the efficacy of each regimen.  In addition, 
Godfrey et al. (5) found that when using these two strategies in a timed AI protocol 
in hair sheep, PGF2α administration yielded significantly lower conception rates 
versus long-term progesterone treatment with a CIDR.  The differences observed 
with timed AI are most likely due to the fact that long-term progesterone treatment 
yields a more narrow range of synchrony and thus prediction of the time of ovulation 
is more reliable, resulting in higher conception rates.  However, there were no 
differences between the two protocols when natural service was used instead of 
timed AI.  
Regardless of the synchronization protocol, the sheep industry is in desperate 
need of an acceptable method of controlling estrus.  The seasonal breeding exhibited 
by most breeds of sheep has resulted in a highly variable supply of lamb (6, 7).  The 
variability in supply has been detrimental to the sheep industry due to inefficiencies 
associated with lamb feeders and packers in regards to labor and capital utilization.  
In addition, the laws of supply and demand coupled with seasonal breeding has 
resulted in lower prices for the majority of producers who are unable to take 
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measures to alter their production systems (7).  By implementing synchronization 
technologies, producers can better manage time, labor, pasture and feed resources.  
In addition to increasing efficiency, producers have the opportunity to increase 
revenues by marketing their product at a more favorable time of year or by 
accelerating the lambing rate of the flock (6, 8). 
  Synchronization of ewes during their normal breeding season can be performed 
with relative ease using either progestin treatment or PGF2α administration.  
However, in the non-cycling ewe, administration of PGF2α is ineffective due to the 
lack of a functional CL to undergo luteolysis.  Therefore, the control of estrus in the 
non-cycling ewe is limited to progesterone treatment.  Due to the aforementioned 
impracticality associated with daily injections of progesterone, most current research 
has focused on the intravaginal administration of this steroid.  The first intravaginal 
administration of progestins came with the development of the intravaginal sponge.  
Next, the intravaginal CIDR was developed, which was constructed with a silicone 
elastomer containing exogenous progesterone (6, 9).  The CIDR replaced the sponge 
primarily due to aesthetic reasons.  Sponges absorb vaginal secretions and are thus 
less desirable to handle upon removal compared to the non-absorbent silicone 
covering of the CIDR (6).  Regardless of the route of administration of the long term 
progesterone treatment, the accompaniment of this treatment with an injection of 
pregnant mare serum gonadotropin (PMSG) upon cessation of progesterone 
treatment is beneficial when breeding out-of-season.  The additional administration 
of PMSG stimulates the preovulatory follicular development leading to an increased 
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ovulation rate (6, 7).  Hamra et al. (10) and Wheaton et al. (11) found that CIDR 
treatment alone was ineffective in inducing estrus in ewes during late spring.  It was 
however shown by Wheaton et al. (11) that in late July CIDR treatment alone was 
effective in inducing estrus and indicates an increase in receptiveness to progesterone 
by ewes following the summer solstice.  CIDR treatment alone in the late winter 
months was also sufficient in inducing estrus and yielded a pregnancy rate of 94.5% 
following natural service (9).   
  Attempts have been made to achieve acceptable levels of estrus synchrony and 
ovulation rates without PMSG administration.  Omitting PMSG from the 
synchronization protocol would reduce the cost associated with the procedure (9).  
The use of the ram effect immediately following CIDR removal to induce estrus has 
proven to be beneficial.  Welch et al. (12) reported that removal of PMSG from the 
synchronization protocol made little difference in the number of ewes exhibiting 
estrus when rams were introduced immediately following CIDR removal.  Further 
research by Wheaton et al. (8) showed that CIDR removal followed by immediate 
introduction of rams successfully stimulated breeding in both late spring and early 
summer.  Research on Elds deer (Cervus eldi thamin) observed a similar trend in that 
stag exposure advances the LH surge and the onset of behavioral estrus over that of 
isolated females (13).  In the sable antelope however, male presence had no effect on 
the timing of ovulation when does were synchronized with CIDR devices (3). 
  Early research involved in the development of the CIDR focused on determining 
the optimal dosage level.  CIDRs containing 3, 6, 9, and 12% progesterone were 
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designed and tested.  CIDRs containing 3% progesterone were ineffective in 
inhibiting estrus and were thus discontinued.  Subsequent research revealed higher 
plasma progesterone concentrations and equal or greater fertility in the 9% and 12% 
CIDRs over that induced by the 6% devices (9).  Further research comparing the 9% 
and 12% devices revealed comparable circulating progesterone levels and thus 9% 
(0.37g) devices were chosen for mass production due to a reduction in cost resulting 
from decreased progesterone requirements (9).  Treatment with these CIDR devices 
is most commonly over a range of 12 to 16 days (1, 3, 6, 10, 14, 15). 
Although it seems that the use of CIDRs to control estrus in sheep would be 
beneficial to the sheep industry, research into the effects of long-term progesterone 
treatment on circulating progesterone levels and subsequent fertility, sperm transport, 
endocrine function, and embryonic growth and development must be evaluated.  
Treatment of livestock with long-term progesterone and its synthetic analogues has 
been known to have various effects on circulating progesterone levels and 
subsequent follicular activity and fertility.  Prior research has shown that in a normal 
cyclic ewe plasma progesterone levels will reach a maximum level of approximately 
2-3 ng/ml between days 8 and 12 of the estrous cycle (16).  Herriman et al. (17) 
observed much higher mean circulating plasma progesterone concentrations of up to 
6 ng/ml on day 11 in normal cyclic ewes.  These differences could potentially be 
breed related.  The lowest plasma progesterone concentrations are observed at the 
time of estrus and reach levels as low as .12 ng/ml as detected by Thorburn et al (16).  
This lowest value is similar to levels found in anestrous and ovariectomized ewes as 
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well as in wethers.  Schrick et al. (18) evaluated serum progesterone profiles in both 
cyclic and pregnant ewes and observed maximal concentrations of approximately 3 
ng/ml in cyclic ewes and between 3-4 ng/ml in pregnant ewes with maximal values 
observed between day 12 and 13 of the estrous cycle. 
In cattle, peripheral plasma progesterone concentrations reach levels of 6 to 8 
ng/ml between days 9 and 16 of the estrous cycle before falling to their lowest 
concentrations of approximately 0.25 ng/ml at the time of estrus (17, 19).  These 
lowest concentrations at the time of estrus were similar to those observed by Nation 
et al. (20) in normal anestrous dairy cows.  Again, variations do exist as shown by 
Herriman et al. (17) and Roberson et al. (21) who observed plasma progesterone 
concentrations of around 10 ng/ml in cyclic dairy heifers and beef cows, 
respectively.  In heifers where serum progesterone concentrations were measured, 
Burke et al. (22) found maximal levels of 3 ng/ml around day 14 and basal levels of 
less than 0.25 ng/ml at the time of estrus. 
Evaluations of preliminary research in sheep on plasma progesterone 
concentrations following estrous synchronization with CIDRs have shown variable 
results.  In an initial study by Hamra et al. (15) it was shown that within 24 hours of 
CIDR insertion, progesterone levels had risen to near maximal levels of 2.1 ng/ml, 
reached peak levels of 2.4 ng/ml on day 4, and then declined steadily to a 
concentration of 1.5 ng/ml on day 13.  When compared to progesterone levels 
observed during treatment with progesterone sponges, which yielded mean 
concentrations of 1.0 ng/ml over the 13 day treatment period, CIDRs produced 
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significantly higher mean levels of circulating progesterone, especially evident in the 
latter portion of the treatment period.  Later research by Ainsworth and Downey (23) 
using 12% CIDRs in ovariectomized ewes showed peak concentrations of 5.5 ng/ml 
within 2 hours of insertion with a subsequent rapid decrease following a curvilinear 
pattern to a low of 1.7 ng/ml on day 13. 
In a study by Wheaton et al. (9) to reveal the effects of CIDRs on plasma 
progesterone concentrations over an extended period of time, cyclic ewes were 
treated with a CIDR for a period of 45 days.  Insertion of CIDRs during the luteal 
phase of these cyclic ewes resulted in maximal progesterone levels of 4.5 ng/ml and 
fell to 0.5 ng/ml by day 27 to day 31.  During this period of treatment, estrous was 
not exhibited at the first expected date.  However by day 31, all ewes had ovulated as 
shown by a subsequent rise in progesterone levels. The occurrence of an ovulation as 
revealed by the progesterone concentrations was however, not accompanied by a 
behavioral estrous (9). 
Interestingly, Haresign (24) evaluated the rate of decline of plasma progesterone 
concentrations following progesterone implant removal compared to the rate of 
decline during luteolysis in a natural cycle.  The resulting research showed an 
increase in the mean rate of decline of plasma progesterone levels by 9-fold 
following implant removal compared to natural luteolysis.  A similar dramatic 
increase in the secretion of tonic LH was observed and substantiates the role of 
progesterone in regulation of LH.  Godfrey et al. (5) compared estrous 
synchronization protocols using PGF2α, progesterone sponges, and progesterone 
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CIDRs.  They found that progesterone concentrations in ewes at the time of ram 
introduction were higher in PGF2α treated ewes than those of sponge and CIDR 
treatments.  No differences in rate of decline in progesterone levels prior to estrus 
were observed between the three protocols.  Additionally, evaluation of a period of 
16 days following the synchronized estrus revealed similar progesterone 
concentrations between the three treatments and concentrations were similar to those 
seen in normal cyclic ewes with normal corpora luteal formation (5). 
In cattle, progesterone treatment yields similar results to those seen in sheep.  
Macmillan and Peterson (1) analyzed plasma progesterone concentrations in 
ovariectomized cows treated with a CIDR-B device for 12 days.  The study revealed 
mean plasma progesterone concentrations of 6.7 ng/ml on day 1 following device 
insertion and falling to a mean concentration of 2.3 ng/ml 3 days following device 
removal.  Burke et al. (25) evaluated plasma progesterone concentrations during 
treatment with a CIDR alone and accompanied with estradiol benzoate.  CIDRs were 
inserted on day 13 of a natural estrous cycle and subsequent plasma progesterone 
concentrations increased from 6.7 to 10 ng/ml within 2 hours of CIDR insertion.  
However, on day 3 and 5 post treatment no significant differences in progesterone 
concentrations were observed between treatment and control groups.  Previous 
research by Burke et al. (26) showed that CIDR device insertion maintained 
circulating progesterone levels above 2 ng/ml for at least 7 days in ovariectomized 
cows.  Burke et al. (25) have thus postulated that either endogenous progesterone 
secretion may decline in cyclic cattle and/or progesterone metabolism may increase 
                                                                                                                                                                         
 
11
in response to higher circulating progesterone concentrations due to progesterone 
treatment. 
Research done by Munro was the first to compare trends in plasma progesterone 
profiles between CIDR devices and progesterine releasing intravaginal devices 
(PRIDs) containing two different dosage levels.  He found that regardless of 
treatment type, mean progesterone levels prior to treatment (0.6 ng/ml) were not 
significantly different than concentrations observed 24 and 48 hours post treatment 
(0.7 and 0.6 ng/ml respectively).  Upon initiation of the treatments, concentrations 
rose rapidly to levels of about 11 ng/ml on day 1 and declined to lows of about 4 
ng/ml on day 14 of treatment.  Upon statistical analysis, no significant differences 
between treatments were observed (27).  Similar profiles following PRID insertion 
were observed again by Munro one year later (28). 
Munro and Moore (29) also compared plasma progesterone concentrations in 
ovariectomized and prepubertal heifers upon treatment with intramuscular injections 
and intravaginal administration of progesterone.  Results of this experiment indicated 
that progesterone concentrations following intravaginal administration more closely 
resembled those of a normal luteal phase than concentrations observed during daily 
injection treatment.  This may be due to rapid spikes in concentrations followed by 
return to near basal levels prior to the next injection resulting in an unphysiologic 
pattern as seen in rats and mice (30).  Evaluation of differences between 
ovariectomized heifers and prepubertal heifers in regards to progesterone 
concentrations following PRID insertion were also observed.  In ovariectomized 
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heifers, PRIDs maintained progesterone concentrations of 6-8 ng/ml for 6 to 7 days 
while in prepubertal animals these concentration levels were maintained for over 14 
days (29).  This observation suggests that factors such as prior stimulus to sex 
hormones before ovariectomy could have effects upon treatments following ovary 
removal.   
Research has shown that long-term progesterone treatment elicits effects on 
fertility and endocrine function.  Preliminary research using exogenous progesterone 
to synchronize estrous cycles showed effective control of both estrus and ovulation, 
however fertility of controlled estrus was reduced following long-term (17-21 day) 
progestin treatment (31, 32, 33).  Similarly, Robinson (34) and Robinson et al. (35) 
found that long-term progestin treatment in sheep decreased fertility at the 
synchronized estrus.  Later research showed that if progestin treatment could be 
reduced to 10-12 days by accompanying this treatment with a luteolytic agent, 
conception rates were normal (4, 36, 37, 38, 39).  In a long versus short-term 
intravaginal treatment of progestagens in heifers, it was revealed that decreasing 
length of progestagen administration from 20 days to 10 days resulted in an increase 
of about 12% in conception rate.  An 18% reduction in conception rate was observed 
between heifers treated for 20 days versus untreated control heifers (40).  In a study 
by MacMillan and Peterson (1), a reduction in the length of progesterone treatment 
via CIDR from 21 to 14 to 7 days + PGF2α revealed a subsequent increase in 
percent calving rate to 1st service from 39.8 to 45.8 to 60.5% respectively.  As in 
cattle, a reduction in the number of days of progesterone treatment in sheep has 
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shown increases in conception rates over those first observed in preliminary 
research, to levels comparable to normal untreated ewes (41, 42). 
In a recent study by Wehrman et al. (43) conception rates were compared 
between cows receiving a 10-day exogenous progesterone treatment with either 1 or 
2 PRIDs.  Results showed an increase in conception rate following AI in cows 
receiving 2 PRIDs over those only receiving one.  These researchers hypothesized 
that the decreased fertility associated with the lower progesterone concentrations 
observed in single PRID treated cows were characteristic of a luteal phase deficiency 
and was the result of an extended period of exposure to 17β estradiol.  This reduction 
in fertility due to luteal function deficiencies has been previously characterized in 
cattle (44, 45, 46, 47). 
Johnson et al. (48) observed similar reductions in fertility in ewes due to 
treatment with progesterone and attributed it to an increase in circulating estradiol 
produced by older ovulatory follicles.  Conception rates in ewes with higher 
concentrations of estradiol prior to mating were lower than conception rates in ewes 
with low concentrations of estradiol.  A dose dependant response on fertility has 
been observed in sheep.  Robinson et al. (35) found that fertility increased as dosage 
levels increased over a given treatment time period.  This inverse relationship 
between progesterone and estradiol concentrations is interesting for synchronization 
programs when estrus detection is required.  The conception rates associated with the 
relative concentrations of these hormones have been characterized.  However, there 
is also an interesting inverse relationship between these two hormones on estrus 
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behavior.  Davidge et al. (49) found that an increase in the dosage and resultant 
concentrations of progesterone yielded a dramatic decrease in mounts received and 
stands observed in these cows.  This could potentially have dramatic effects on 
research if estrus detection is less than optimal.  This also bodes well for the use of 
timed AI when estrus synchronization is achieved using protocols that incorporate 
progesterone into the regimen. 
The observation of reduced fertility in long-term progesterone treated animals 
stimulated research into the cause of this decline.  It has been speculated that the 
relative concentrations of progesterone and estradiol could potentially affect sperm 
transport in the female reproductive tract, follicular development, and early 
embryonic development.  Early research focused on the effects of progestin 
treatment on sperm transport.  Allison and Robinson (50) evaluated three different 
dosage levels of progestagens and found that as dosage increased the number of tubal 
spermatozoa and lambing percentage both rose.  Other research showed that 17β-
estradiol plays an inhibitory role in the movement of sperm through the female 
reproductive tract (51, 52).  These findings are consistent with early research that 
showed that insufficient dosages of progestins along with a corresponding increase in 
17β-estradiol concentrations were characteristic of a luteal deficiency and yielded 
reduced fertility.  Later research by Pearce and Robinson (53) illustrated similar 
results showing an increase in the number of spermatozoa located within the cervix 
as dose levels of progesterone increased from 200 to 400 to 600 mg.  However, 
progesterone concentration profiles from the three treatments were not significantly 
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different and thus the observation of reduced spermatozoa could not be associated 
with insufficient plasma progesterone concentrations.  Instead, these researchers 
postulated that the reduction in spermatozoa was due to the rapid decline in 
progesterone concentrations following sponge removal and the resulting prolonged 
interval between progesterone treatment and an observed estrus and subsequent 
insemination.   
Research attempting to reveal more insight into reasons for reduced fertility 
focused on the prolonged exposure to 17β-estradiol and its association with luteal 
deficiencies.  This research postulated that altered follicular development could 
result in improper oocyte development, or an improper uterine environment could 
develop which is not conducive to early embryonic growth (43).  Changes in steroid 
concentrations have been shown to be associated with structural changes during 
oocyte maturation and are thought to prevent premature nuclear maturation (54).  In 
addition, low doses of progesterone have been shown to extend the life span of some 
dominant ovarian follicles if progesterone treatment is initiated just prior to or at the 
normal time of luteolysis (55, 56, 57).  This prolonged dominance may lead to the 
development of an abnormal oocyte, which upon ovulation has reduced fertility.  
Furthermore, formation of a CL from this abnormal follicle may result in an irregular 
luteal phase and thus early embryonic mortality (55).  Future research will 
undoubtedly reveal the mechanism associated with reduced fertility associated with 
long-term progesterone treatment, although the addition of a luteolytic factor with 
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slightly shorter treatment duration can be used to reduce detrimental effects of 
progesterone administration. 
Specifically, in regards to progesterone treatment via CIDR device, the analysis 
of the progesterone concentration profiles is the first step needed for determination 
of the efficacy of this synchronization tool.  From this point, investigation into 
achieving optimal fertility and the development of a comprehensive regimen that is 
effective and economically viable for the sheep industry can be undertaken.   
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MATERIALS AND METHODS 
 A long-term progesterone treatment via vaginal delivery system trial was 
conducted at the Sheep and Goat Center in the Animal Science Teaching Reasearch 
Extension Complex (ASTREC) of Texas A & M University, College Station, Texas.  
The trial began on October 4, 2000 and concluded on December 7, 2000.  All 
procedures used in this study were approved by the Institutional Animal Care and 
Use Committee at Texas A & M University.  A homogenous group of thirty-one 
cycling, multiperous crossbred ewes were evaluated for differences in circulating 
levels of progesterone before, during, and after implantation with a progesterone 
CIDR.  A twenty-five day sampling period was observed prior to CIDR implantation 
to ensure that each ewe displayed a complete estrous cycle.  A twelve-day sampling 
period then ensued during which time exogenous progesterone was administered to 
each ewe via the CIDR.  Following removal on day twelve of treatment, these ewes 
were placed with either intact or vasectomized rams to determine if there was an 
induction of estrus and an addition twenty-five day sampling period was undertaken.   
Ewe Preparation 
 Prior to initiation of the study, ewes were sonogrammed to determine 
reproductive status.  Ewes were randomly confined to two equal sized bermuda grass 
paddocks 15 m wide by 86 m long.  Ewes were supplemented with free choice 
alfalfa hay and 2.2 kg of whole corn daily to maintain an acceptable body condition.  
Shearing of the neck was performed prior to initiation of the study as well as once 
during the study to facilitate jugular venipuncture. 
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Blood Collection and Handling 
Blood samples were collected at 0700 daily via jugular venipuncture into 
Vacutainer Evacuated Blood Collection Tubes (Becton-Dickinson, Franklin Lake, 
NJ).  The blood samples were allowed to coagulate at room temperature for one hour 
prior to serum extraction.  Following the coagulation period, samples were spun at 
1500 rpm for 15 minutes at room temperature to separate the various blood 
components.  The serum was then removed from the blood collection tubes and 
stored in individually labeled plastic tubes.  The serum was stored at -20°C until 
analyzed.  Concentration of progesterone in serum samples were later determined 
using an Active Progesterone Radioimmunoassay kit (Diagnostic Systems 
Laboratories, Inc., Webster, TX).  Assay results were calculated using the AssayZap 
program (Biosoft, Ferguson, CA).   Assay sensitivity was 0.10 ng/ml.  The intra- and 
inter- assay variations were 17.37 and 15.96%, respectively, which fall within the 
acceptable limits of the test. 
Statistical Analysis 
Data was analyzed by least squares analysis of variance (ANOVA) using the 
general linear models procedure of the Statistical Analysis System (Cary, NC) (58).  
Least square means were generated from ANOVA and are presented with standard 
errors.    
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RESULTS AND DISCUSSION 
During the course of the study it was determined that three of the ewes were in 
fact pregnant and therefore they and their previously collected blood samples were 
removed from the study. 
Pre-implantation Progesterone Levels 
The pre-implantation or control period of the study was analyzed to determine 
two characteristics: cyclicity and control serum progesterone levels.  During this 
initial period, it was determined that progesterone levels in peripheral circulation 
changed (P < 0.0001, effect of day).  Changes in peripheral circulating levels of 
progesterone were in accordance with the stage of the estrous cycle and were 
elevated during the luteal phase.  Mean circulating progesterone concentration during 
the pretreatment estrous cycle was 1.3 ± 0.1 ng/ml.  This is similar to that observed 
by Oladimeji et al. (59) of 1.57 ng/ml observed in Yankasa ewes during the late wet 
season. Mean peak serum progesterone level during this stage of the experiment was 
4.71 ± 0.46 ng/ml with peak values observed on day 11 of the estrous cycle with a 
range from day 7 to day 15-post estrus, determined by day of lowest serum 
progesterone concentration.  Bartlewski et al. (60) observed peak serum progesterone 
levels of around 4 ng/ml on two representative Western white-faced ewes, however 
when they analyzed serum progesterone concentrations in two representative Finn 
ewes they observed peak serum concentrations of around 3 ng/ml.  Differences in 
this study between breeds were statistically significant (P < 0.05) with Western-
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white faced ewes having higher peak serum progesterone levels from Day 4 to Day 
14 of the estrous cycle than Finn ewes.   
Schrick et al. (18) observed peak serum progesterone concentrations of slightly 
over 3.0 ng/ml in a group of 36 mature ewes of predominately Suffolk cross descent.  
Peak serum progesterone concentrations observed in our study are slightly higher 
than those seen by other researchers, however are similar to those observed by 
Bartlewski et al. (60) in Western white-faced ewes.  Animals used in this study are a 
cross between Suffolk and Western white-faced sheep and thus could potentially 
validate the slightly higher levels observed in our study based upon variability 
between breeds.   
Mean minimum circulating levels of serum progesterone in our study were 
observed at the time of estrus, as expected, and were below the sensitivity of the 
assay which was 0.10 ng/ml.  These levels are similar to those seen by Bartlewski et 
al. (60) of 0.12 ng/ml at this stage of the estrous cycle.   
Effect of CIDR Treatment on Progesterone Levels 
In comparison to the pre-implantation period it was found, as expected, that 
circulating serum progesterone levels were elevated (P < 0.0001; 1.3ng/ml vs. 2.4 
ng/ml, respectively) in ewes following insertion of the CIDR device.  Mean peak 
levels of serum progesterone were observed on Day 5 of CIDR treatment with a 
mean peak concentration of 3.27 ng/ml.  The concentration fell to its lowest level on 
the final day of treatment to a mean level of 1.26 ng/ml (Figure 1).  This pattern of 
increase to maximum and then decline is similar to that seen by Hamra et al. (15). 
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These researchers observed peak plasma progesterone levels of 2.2 ± 0.3 ng/ml on 
day four of treatment using a 9% CIDR device with declining levels to 1.4 ± 0.2 
ng/ml on day thirteen of treatment.  Wheaton et al. (9) observed almost identical 
results such that peak plasma progesterone concentrations of 2.4 ng/ml were 
observed on day four of treatment (Day 0 characterized by day of CIDR insertion) 
and declined in a gradual manner until day thirteen where levels were down to 1.5 
ng/ml. 
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Figure 1.  Mean progesterone concentrations during treatment with progesterone CIDR device. 
 
Pre-implantation Versus Post-implantation Levels     
The final comparison of this study was a characterization of the estrous cycle 
immediately following the removal of the CIDR compared to the estrous cycle 
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immediately prior to CIDR insertion.  Only, the first fifteen days of each respective 
estrous cycle were analyzed for mean circulating serum progesterone concentrations 
due to inadvertant exposure to intact rams during the time of estrus.   
As previously stated we observed a pre-implantation mean progesterone 
concentration of 1.3 ± 0.1 ng/ml versus a 1.4 ± 0.1 ng/ml mean circulating 
progesterone concentration in the estrous cycle immediately following CIDR 
removal.  Mean values of circulating progesterone levels were not statistically 
significantly different (P > 0.10) between period 1 and period 3.  A comparison of  
 representative estrous cycles for ewe number twelve pre- and post-implantation can 
be found below (Figure 2).   
 
Figure 2.  A representative comparison of the estrous cycles of ewe #12 before and after treatment via  
progesterone CIDR device. 
 
 
 In an evaluation of the estrous cycle following CIDR treatment, Godfrey et al. 
(5) found that progesterone profiles were characteristic of normal luteal formation 
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and function.  In our study, mean peak progesterone levels in the post-implantation 
estrous cycle were 4.23 ± 0.46 ng/ml.  The peak concentration in this study in the 
post-implantation period was slightly lower however not significantly different (P = 
0.4605) than peak concentrations observed in the pre-implantation estrous cycle 
(Figure 3). 
  
Figure 3.  A comparison of the mean peak progesterone levels in the estrous cycle immediately prior 
to and the estrous cycle immediately following a twelve-day treatment via progesterone CIDR device. 
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                                              SUMMARY 
Results of this study were in line with our expectations and paralleled the 
findings of other researchers.  As expected, the insertion of a progesterone CIDR 
device increased circulating serum progesterone levels to a level higher than mean 
progesterone concentrations during the pre-treatment cycle.  These progesterone 
concentrations were, however, characteristic of levels that could be observed during 
the luteal phase of any untreated ewe.  
When comparing the pre- and post-implantation estrous cycles there were no 
differences in mean or peak circulating serum progesterone concentrations.  This 
indicates that upon CIDR removal circulating serum progesterone is quickly 
removed from the blood stream, which allows a relatively rapid induction into estrus 
and a resulting seemingly normal and characteristic estrous cycle.   
One concern with using implants such as a progesterone CIDR device is the 
ability of the body to store those compounds in various tissues.  It is known that 
adipose tissue stores progesterone, however at least with this form of natural 
progesterone there is seemingly no slow release from these tissues following CIDR 
removal, which is evidenced by the seemingly normal circulating progesterone 
concentrations in the estrous cycle following treatment.  
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